Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation

Liver cancer: Common anesthetic can accelerate tumor progression Researchers warn against using the anesthetic dexmedetomidine (DEX) in liver cancer patients after indications that it promotes tumor growth. Concerns have been raised that certain anesthetics, including DEX, can accelerate the progres...

Full description

Bibliographic Details
Main Authors: Peng Chen, Xiaojun Luo, Guanqi Dai, Yuchuan Jiang, Yue Luo, Shuang Peng, Hao Wang, Penghui Xie, Chen Qu, Wenyu Lin, Jian Hong, Xue Ning, Aimin Li
Format: Article
Language:English
Published: Nature Publishing Group 2020-07-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-020-0461-6

Similar Items

Similar Items